Literature DB >> 10955391

Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy.

V Klauss1, A König, C Spes, B Meiser, J Rieber, U Siebert, E Regar, M Pfeiffer, B Reichart, K Theisen, H Mudra.   

Abstract

This study prospectively compared the impact of cyclosporine A and tacrolimus on the development of cardiac allograft vasculopathy. By using serial intravascular ultrasound examinations, a trend toward a more pronounced progression was noted in the tacrolimus group in the first year after heart transplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955391     DOI: 10.1016/s0002-9149(99)00631-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Transplant Coronary Vasculopathy.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-02

Review 2.  Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.

Authors:  Luciano Potena; Hannah A Valantine
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 3.  Outcomes and survival following heart retransplantation for cardiac allograft failure: a systematic review and meta-analysis.

Authors:  Syed-Saif Abbas Rizvi; Jessica G Y Luc; Jae Hwan Choi; Kevin Phan; Ester Moncho Escrivà; Sinal Patel; H Todd Massey; Vakhtang Tchantchaleishvili
Journal:  Ann Cardiothorac Surg       Date:  2018-01

Review 4.  Cardiovascular effects of immunosuppression agents.

Authors:  Aly Elezaby; Ryan Dexheimer; Karim Sallam
Journal:  Front Cardiovasc Med       Date:  2022-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.